User:Kam1296/sandbox

Works Cited

Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002;94:894–903.

- Source from the US National Library of Medicine - Research on 80 families with a history of melanoma and screens if the CDKN2A mutation in their genes. This study shows what common familial history people have who carry the mutated gene. -Unbiased Medical research article

Hensin Tsao, Kristin Niendorf, Genetic testing in hereditary melanoma, Journal of the American Academy of Dermatology, Volume 51, Issue 5, November 2004,Pages 803-808, ISSN 0190-9622,

- Journal of the American Academy of Dermatology - Provides information about genetic testing upon those who have tested positive for the CDKN2A gene for Melanoma. - Unbiased Medical Journal Pérez-Lorenzo R, Zheng B. Targeted inhibition of BRAF kinase: Opportunities and challenges for therapeutics in melanoma. Biosci Rep. 2012;32(1):25–33.

- Source form the US National Library of Medicine - Research on the the BRAF kinase-specific small-molecule inhibitors that have showed results in helping cure genetic melanoma. -Unbiased Medical research

R. Kefford, J.N. Bishop, M. Tucker, B. Bressac-de Paillerets, G. Bianchi-Scarra, W. Bergman, et al. Genetic testing for melanoma Lancet Oncol, 3 (2002), pp. 653– 654

- Source from the US National Library of Medicine - Talks about the different procedures for testing for the specific mutation of genetic melanoma(CDK2NA) on chromosome 9. - Unbiased medical research

Solit DB, Rosen N. Resistance to BRAF inhibition in melanomas. N Engl J Med. 2011;364(8):772–774.

- Source from the US National Library of Medicine - Research on BRAF for helping cure genetic melanoma. -Unbiased Medical Research